1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models
- 2018
- Small-molecule inhibitor of OGG1 suppresses proinflammatory gene expression and inflammation
- 2012
- Inhibition mechanism of human galectin-7 by a novel galactose-benzylphosphate inhibitor.